Current and Potential Treatments for Cervical Cancer

Author(s): Grace P.C. Yee, Paul de Souza, Levon M. Khachigian

Journal Name: Current Cancer Drug Targets

Volume 13 , Issue 2 , 2013

Become EABM
Become Reviewer


Cervical cancer is the third most common carcinoma in women worldwide. Despite increasing efforts to improve therapy in this disease, a significant proportion of women still die, mostly from recurrent or chemoresistant disease. This review discusses current treatments for early cervical cancer, advanced disease, and recurrent cervical cancer, and covers concurrent chemoradiation, neoadjuvant chemotherapy before surgery and radiation, single agent treatment, combination treatment, platinum-based and non-platinum based therapy. We also discuss promising therapeutic strategies for cervical cancer including targeted therapy, cell-based therapy, combined siRNA and chemotherapy, and immunotherapy.

Keywords: Cervical cancer, side-effects, targeted, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 11 March, 2013
Page: [205 - 220]
Pages: 16
DOI: 10.2174/1568009611313020009
Price: $65

Article Metrics

PDF: 51